[Edaily Reporter YU JIN-HEE ] The largest shareholder of KMPHARMACEUTICAL Co.,Ltd.(225430)has consistently purchased the company’s shares, demonstrating a strong commitment to responsible management and enhancing corporate value. KMPHARMACEUTICAL Co.,Ltd. announced on the 1st that its largest shareholder, Chairman Kang Il-mo, purchased 14,421 shares of the company’s common stock on the open market on two separate occasions—the 26th and 29th of last month.

Including this purchase, the cumulative volume of shares acquired on the open market by the largest shareholder and related parties over the past six months has increased to a total of 45,620 shares. As a result, the ownership stake rose by 0.82 percentage points from the previous level to 39.60%.

The company emphasized that this increase in shareholding is not a temporary measure to boost the stock price in the short term, but rather a reaffirmation of its commitment to the market to enhance corporate value and strengthen responsible management over the medium to long term. In particular, analysts note that the largest shareholder’s decision to increase its stake for six consecutive months reflects firm confidence in the ongoing transition to a business structure centered on its Life Care brand and in its future growth strategy.

In fact, building on the stable foundation of its existing oral care business—including its flagship product, “Pororo Toothpaste”—KMPHARMACEUTICAL Co.,Ltd. is accelerating the development of functional cosmetics and life care brands, as well as its expansion into overseas markets. Recently, the company demonstrated its technological capabilities by completing the registration of a patent related to nanographene materials for its scalp and hair loss care brand, “Zerocipe,” and is actively diversifying its export markets and product lines to countries such as the United States and Asia based on this achievement.

The company is also in the midst of restructuring its business model, which had previously been focused on OEM and ODM production of over-the-counter products. By enhancing the competitiveness of its own brands in the oral care and functional cosmetics sectors, KMPHARMACEUTICAL Co.,Ltd. is making a full-scale push to transform itself into a global life care brand company that appeals to a diverse range of consumers.

A KMPHARMACEUTICAL Co.,Ltd. official stated, “The major shareholder’s continued on-market purchases demonstrate firm confidence in the company’s growth potential and future value,” adding, “We will continue to rigorously practice responsible management to strengthen our business competitiveness and concentrate our company-wide capabilities on improving performance and enhancing shareholder value.”